Consano Medical Scores $3.9M For Intensive Care Monitoring

San Francisco-based Consano Medical, a developer of medical devices focused on the intelligent monitoring of intensive care unit patients, has raised $3.9M in a Series A funding, according to deal funding site Deal Labs. Source of the funding was not disclosed. Consano Medical was spun out of TheraNova, and is led by Dan Burnett. Consano's devices are specifically aimed at detecting and managing sepsis in patients in intensive care units.